About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Ohio | 28,718 Studies Near You

Clinical TrialsOhio

Clinical Trials in Ohio

Discover 28,718 clinical trials near Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4561-4580 of 28,718 trials

CompletedFlowTriever for Acute Massive Pulmonary Embolism (FLAME)To evaluate treatment outcomes of patients diagnosed with high-risk (massive) pulmonary embolismNCT04795167·Atlanta, Georgia and 10 others Enrolling by invitationComprehensive Assessment of Reactions to Pharmacogenetics in Complex Care PatientsThe goal of this clinical trial is to determine the feasibility and acceptability of Pharmacogenetic Testing, and the attitudes towards the same in caregivers of complex care…NCT07060300·Cincinnati, Ohio TerminatedA Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the KneeStudy OA-07 was a randomized, double-blind, placebo-controlled, Phase 3, multicenter, 2-year clinical trial that enrolled subjects from the recently completed Study OA-11…NCT04520607·Tucson, Arizona and 41 others

Find Trials by Condition in Ohio

Breast Cancerin Ohio Lung Cancerin Ohio Prostate Cancerin Ohio Colorectal Cancerin Ohio Melanomain Ohio Leukemiain Ohio Lymphomain Ohio Pancreatic Cancerin Ohio Ovarian Cancerin Ohio Brain Cancerin Ohio Diabetesin Ohio

Data from ClinicalTrials.govTerms

CompletedCombination Chemotherapy in Treating Patients With Advanced Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00039611·Anchorage, Alaska and 18 others

TerminatedStudy of TST005 in Patients With Locally Advanced or Metastatic Solid TumorsThis is an open label Phase 1, first-in-human (FIH) study of TST005, a bi-specific antibody consisting of a PD-L1 monoclonal antibody (mAb) and a transforming growth factor beta…NCT04958434·Canton, Ohio and 2 others

CompletedMajor Depressive Disorder (MDD) With Mixed Features - Flexible DoseLurasidone HCl is a compound that is a candidate for the treatment of major depressive with mixed features.This clinical study is designed to test how well Lurasidone works to…NCT01421134·Birmingham, Alabama and 42 others

CompletedIntra-arterial Melphalan in Treating Younger Patients With Unilateral RetinoblastomaThis pilot clinical trial studies whether unilateral group D retinoblastoma, or retinoblastoma affecting one eye that has spread to the inner jelly like part of the eye, can be…NCT02097134·Los Angeles, California and 11 others

CompletedCisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial CancerThis phase II trial studies how well cisplatin and gemcitabine hydrochloride with or without berzosertib works in treating patients with urothelial cancer that has spread to other…NCT02567409·Phoenix, Arizona and 38 others

CompletedA Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)There was no well accepted standard of care for participants who failed or were intolerant to any of the currently approved therapies for myelodysplastic syndromes (MDS).NCT00531232·Chicago, Illinois and 5 others

TerminatedInduction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's DiseaseThis is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease.NCT03440372·Peoria, Arizona and 407 others

Active not recruitingTECTONIC CAD IVL IDE StudyA prospective, single-arm, open-label, multi-center IDE study with up to 55 US sitesNCT06885177·Scottsdale, Arizona and 39 others

CompletedZoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesRATIONALE: Zoledronate may prevent or decrease skeletal (bone)-related events (such as pain or fractures) caused by bone metastases and androgen deprivation therapy.NCT00079001·Mobile, Alabama and 240 others

CompletedDronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and VomitingThe primary purpose of the study is to determine the efficacy of oral dronabinol versus standard ondansetron antiemetic therapy in preventing delayed-onset chemotherapy-induced…NCT00642512·Tucson, Arizona and 42 others

CompletedDonor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaRATIONALE: Giving low doses of chemotherapy before a donor stem cell transplant helps stop the growth of cancer cells.NCT01027000·Duarte, California and 24 others

CompletedA Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic DermatitisThis study will evaluate crisaborole therapy once daily (QD) as a long-term topical maintenance therapy for the reduction of flare in responders to crisaborole twice daily (BID)…NCT04040192·Fountain Valley, California and 43 others

CompletedAcceptance Of A Partially-Hydrolyzed Infant FormulaThis clinical trial will evaluate stool consistency in infants receiving one of two study formulas through a 14-day feeding period.NCT03223792·Birmingham, Alabama and 10 others

CompletedA Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy RegimenThe purpose of this study is to estimate the incidence and characterize the outcome of high grade, select adverse events in subjects with advanced or metastatic NSCLC treated with…NCT02066636·Mobile, Alabama and 133 others

CompletedSafety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal FunctionPost-operative administration of ipamorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial small and/or large…NCT01280344·Florence, Alabama and 44 others

CompletedEfficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic FibrosisThe purpose of this Randomized, Double-blind, Multicenter, Two-period Crossover Study is to Assess the Efficacy and Tolerability of Burlulipase (NM-BL) in Patients with Exocrine…NCT01710644·Jacksonville, Florida and 8 others

CompletedRituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's LymphomaRATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00392834·La Jolla, California and 12 others

PreviousPage 229 of 1436Next

Heart Diseasein Ohio